These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 1357765
21. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs]. Uchitomi Y, Yamawaki S. Yakubutsu Seishin Kodo; 1987 Sep; 7(3):383-92. PubMed ID: 2894736 [Abstract] [Full Text] [Related]
22. Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat. Baudrie V, Chaouloff F. Eur J Pharmacol; 1991 Jun 06; 198(2-3):129-35. PubMed ID: 1830845 [Abstract] [Full Text] [Related]
25. [3H]WAY-100635 for 5-HT1A receptor autoradiography in human brain: a comparison with [3H]8-OH-DPAT and demonstration of increased binding in the frontal cortex in schizophrenia. Burnet PW, Eastwood SL, Harrison PJ. Neurochem Int; 1997 Jun 06; 30(6):565-74. PubMed ID: 9152998 [Abstract] [Full Text] [Related]
26. [3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe. Johnson RG, Fiorella D, Winter JC, Rabin RA. Eur J Pharmacol; 1997 Jun 18; 329(1):99-106. PubMed ID: 9218690 [Abstract] [Full Text] [Related]
30. Autoradiographic localization and pharmacological characterization of [3H]tandospirone binding sites in the rat brain. Tanaka H, Shimizu H, Kumasaka Y, Hirose A, Tatsuno T, Nakamura M. Brain Res; 1991 Apr 19; 546(2):181-9. PubMed ID: 1648988 [Abstract] [Full Text] [Related]
31. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Burnet PW, Eastwood SL, Harrison PJ. Neuropsychopharmacology; 1996 Nov 19; 15(5):442-55. PubMed ID: 8914117 [Abstract] [Full Text] [Related]
32. Effects of repeated doses of azapirones on rat brain 5-HT1A receptors and plasma corticosterone levels. Matheson GK, Raess BU, Tunnicliff G. Gen Pharmacol; 1996 Mar 19; 27(2):355-61. PubMed ID: 8919656 [Abstract] [Full Text] [Related]
35. Autoradiographic evidence for the interaction of SM-3997 with 5-HT1A receptors in the rat brain. Tanaka H, Shimizu H, Tatsuno T, Hirose A, Kumasaka Y, Nakamura M. Jpn J Pharmacol; 1990 Mar 19; 52(3):504-7. PubMed ID: 1970610 [Abstract] [Full Text] [Related]
36. Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action. Picazo O, López-Rubalcava C, Fernández-Guasti A. Brain Res Bull; 1995 Mar 19; 37(2):169-75. PubMed ID: 7606493 [Abstract] [Full Text] [Related]
37. Species differences in the distribution of central 5-HT1 binding sites: a comparative autoradiographic study between rat and guinea pig. Sijbesma H, Schipper J, Cornelissen JC, de Kloet ER. Brain Res; 1991 Aug 02; 555(2):295-304. PubMed ID: 1834309 [Abstract] [Full Text] [Related]
38. Atypical in vitro and in vivo binding of [3H]S-14506 to brain 5-HT1A receptors. Lima L, Laporte AM, Gaymard C, Spedding M, Mocaër E, Hamon M. J Neural Transm (Vienna); 1997 Aug 02; 104(10):1059-75. PubMed ID: 9503258 [Abstract] [Full Text] [Related]
40. Species differences in regional patterns of 3H-8-OH-DPAT and 3H-zolpidem binding in the rat and human brain. Duncan GE, Knapp DJ, Breese GR, Crews FT, Little KY. Pharmacol Biochem Behav; 1998 Jun 02; 60(2):439-48. PubMed ID: 9632227 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]